Skip to Content
Merck
CN
  • Development of an asymmetric synthesis of a chiral quaternary FLAP inhibitor.

Development of an asymmetric synthesis of a chiral quaternary FLAP inhibitor.

The Journal of organic chemistry (2015-01-07)
Keith R Fandrick, Jason A Mulder, Nitinchandra D Patel, Joe Gao, Michael Konrad, Elizabeth Archer, Frederic G Buono, Adil Duran, Rolf Schmid, Juergen Daeubler, Jean-Nicolas Desrosiers, Xingzhong Zeng, Sonia Rodriguez, Shengli Ma, Bo Qu, Zhibin Li, Daniel R Fandrick, Nelu Grinberg, Heewon Lee, Todd Bosanac, Hidenori Takahashi, Zhidong Chen, Alessandra Bartolozzi, Peter Nemoto, Carl A Busacca, Jinhua J Song, Nathan K Yee, Paige E Mahaney, Chris H Senanayake
ABSTRACT

A practical sequence involving a noncryogenic stereospecific boronate rearrangement followed by a robust formylation with an in situ generated DCM anion has been developed for the asymmetric construction of an all-carbon quaternary stereogenic center of a FLAP inhibitor. The key boronate rearrangement was rendered noncryogenic and robust by using LDA as the base and instituting an in situ trapping of the unstable lithiated benzylic carbamate with the boronic ester. A similar strategy was implemented for the DCM formylation reaction. It was found that the 1,2-boronate rearrangement for the formylation reaction could be temperature-controlled, thus preventing overaddition of the DCM anion and rendering the process reproducible. The robust stereospecific boronate rearrangement and formylation were utilized for the practical asymmetric synthesis of a chiral quaternary FLAP inhibitor.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Cyclopropylboronic acid pinacol ester, 96%